A nephrology unit at Detroit-based Henry Ford Hospital has lowered Clostridioides difficile infections by 90% since 2023. Leaders at the hospital credit the progress to the Comprehensive Unit-based ...

Currently, C. difficile is first treated with antibiotics like vancomycin, against which the bacteria has not developed a ...

AI guidance for clinicians aimed at reducing the spread of Clostridioides difficile—a bacteria that can be deadly for sick ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a ... doses of the shot compared to placebo in the 17,500-patient trial, which enrolled subjects 50 years of age and ...

Nurses and nurse midwives have historically considered patient education one of their most important responsibilities. Increasingly, however, appropriate and comprehensive patient education has ...

a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C ...

GI, Gastrointestinal; CHF, congestive heart failure; PUD, peptic ulcer disease; RUQ, upper right quadrant; SOB, shortness of breath; DOE, dyspnea on exertion; CVA ...